Anderson da Silva

Active pharmacovigilance of the seasonal trivalent influenza vaccine produced by Instituto Butantan: A prospective cohort study of five target groups.

T. Vanni, B. Thomé, L. Weckx, 2021, PloS one.

Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial.

A. Sette, D. Weiskopf, J. Kalil, 2020, The Lancet. Infectious diseases.

Risk factors for adverse outcomes following haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: a two-center analysis

N. Hamerschlak, L. Kerbauy, A. A. Ribeiro, 2021, Annals of Hematology.

Overview of SARS-COV-2 infection at the Butantan Penitentiary Progression Center

J. Aldrighi, P. Braga, Anderson da Silva, 2023, Revista de saude publica.

A randomized, double-blind, non-inferiority trial comparing the immunogenicity and safety of two seasonal inactivated influenza vaccines in adults.

A. Lara, T. Vanni, E. Coelho, 2023, Vaccine.